Publication Information

{'id': 'https://openalex.org/W2941833785', 'doi': 'https://doi.org/10.1097/01.ju.0000556616.79234.d6', 'title': 'MP57-20 PARP INHIBITORS AS POTENTIAL THERAPEUTIC AGENTS AGAINST BLADDER CANCER', 'display_name': 'MP57-20 PARP INHIBITORS AS POTENTIAL THERAPEUTIC AGENTS AGAINST BLADDER CANCER', 'publication_year': 2019, 'publication_date': '2019-04-01', 'ids': {'openalex': 'https://openalex.org/W2941833785', 'doi': 'https://doi.org/10.1097/01.ju.0000556616.79234.d6', 'mag': '2941833785'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.ju.0000556616.79234.d6', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556616.79234.d6', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556616.79234.d6', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101685632', 'display_name': 'Matthew Sullivan', 'orcid': 'https://orcid.org/0000-0002-5112-7621'}, 'institutions': [{'id': 'https://openalex.org/I90871651', 'display_name': 'University of Toledo', 'ror': 'https://ror.org/01pbdzh19', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I90871651']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Matthew Sullivan', 'raw_affiliation_strings': ['Toledo, OH'], 'affiliations': [{'raw_affiliation_string': 'Toledo, OH', 'institution_ids': ['https://openalex.org/I90871651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065411694', 'display_name': 'Sayani Bhattacharjee', 'orcid': 'https://orcid.org/0000-0001-8781-5867'}, 'institutions': [{'id': 'https://openalex.org/I90871651', 'display_name': 'University of Toledo', 'ror': 'https://ror.org/01pbdzh19', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I90871651']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sayani Bhattacharjee', 'raw_affiliation_strings': ['Toledo, OH'], 'affiliations': [{'raw_affiliation_string': 'Toledo, OH', 'institution_ids': ['https://openalex.org/I90871651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024881005', 'display_name': 'Rebecca Wynn', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I90871651', 'display_name': 'University of Toledo', 'ror': 'https://ror.org/01pbdzh19', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I90871651']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Wynn', 'raw_affiliation_strings': ['Toledo, OH'], 'affiliations': [{'raw_affiliation_string': 'Toledo, OH', 'institution_ids': ['https://openalex.org/I90871651']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5070199787', 'display_name': 'Nagalakshmi Nadiminty', 'orcid': 'https://orcid.org/0000-0003-3408-3206'}, 'institutions': [{'id': 'https://openalex.org/I90871651', 'display_name': 'University of Toledo', 'ror': 'https://ror.org/01pbdzh19', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I90871651']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nagalakshmi Nadiminty*', 'raw_affiliation_strings': ['Toledo, OH'], 'affiliations': [{'raw_affiliation_string': 'Toledo, OH', 'institution_ids': ['https://openalex.org/I90871651']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.243, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.521278, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 61, 'max': 69}, 'biblio': {'volume': '201', 'issue': 'Supplement 4', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/synthetic-lethality', 'display_name': 'Synthetic Lethality', 'score': 0.65047157}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.76643825}, {'id': 'https://openalex.org/C2778502085', 'wikidata': 'https://www.wikidata.org/wiki/Q7662767', 'display_name': 'Synthetic lethality', 'level': 4, 'score': 0.65047157}, {'id': 'https://openalex.org/C2780352672', 'wikidata': 'https://www.wikidata.org/wiki/Q504775', 'display_name': 'Bladder cancer', 'level': 3, 'score': 0.614792}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.54783666}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.46561503}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.4596391}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.43145037}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.38226935}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3783272}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33410382}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.15104038}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.13342524}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.117836505}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.ju.0000556616.79234.d6', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556616.79234.d6', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1097/01.ju.0000556616.79234.d6', 'pdf_url': 'https://www.auajournals.org/doi/pdf/10.1097/01.JU.0000556616.79234.d6', 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.52}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4309859277', 'https://openalex.org/W2801224314', 'https://openalex.org/W2747908831', 'https://openalex.org/W2614504158', 'https://openalex.org/W2614456022', 'https://openalex.org/W2548423821', 'https://openalex.org/W2261933510', 'https://openalex.org/W2105589846', 'https://openalex.org/W2101012300', 'https://openalex.org/W1985047304'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 120, 134, 163, 185, 194, 211, 223, 238, 266, 294, 302, 315, 349, 370, 399, 404, 436, 442, 458, 484], 'UrologyBladder': [4], 'Cancer:': [5], 'Basic': [6], 'Research': [7], '&': [8, 509], 'Pathophysiology': [9], 'II': [10], '(MP57)1': [11], 'Apr': [12], '2019MP57-20': [13], 'PARP': [14, 195, 204, 316, 443, 447, 455], 'INHIBITORS': [15], 'AS': [16], 'POTENTIAL': [17], 'THERAPEUTIC': [18], 'AGENTS': [19], 'AGAINST': [20], 'BLADDER': [21], 'CANCER': [22], 'Matthew': [23, 32, 521], 'Sullivan,': [24], 'Sayani': [25, 41, 528], 'Bhattacharjee,': [26], 'Rebecca': [27, 50, 535], 'Wynn,': [28], 'and': [29, 59, 95, 141, 188, 256, 285, 304, 322, 339, 381, 389, 462, 498, 517], 'Nagalakshmi': [30, 60, 542], 'Nadiminty*': [31, 62, 543], 'SullivanMatthew': [33], 'Sullivan': [34, 522], 'More': [35, 44, 53, 63, 523, 530, 537, 544], 'articles': [36, 45, 54, 64, 524, 531, 538, 545], 'by': [37, 46, 55, 65, 227, 493, 512, 525, 532, 539, 546], 'this': [38, 47, 56, 66, 526, 533, 540, 547], 'author': [39, 48, 57, 67, 527, 534, 541, 548], ',': [40, 49, 58], 'BhattacharjeeSayani': [42], 'Bhattacharjee': [43, 529], 'WynnRebecca': [51], 'Wynn': [52, 536], 'Nadiminty*Nagalakshmi': [61], 'View': [68], 'All': [69, 550], 'Author': [70], 'Informationhttps://doi.org/10.1097/01.JU.0000556616.79234.d6AboutPDF': [71], 'ToolsAdd': [72], 'to': [73, 198, 241, 335], 'favoritesDownload': [74], 'CitationsTrack': [75], 'CitationsPermissionsReprints': [76], 'ShareFacebookLinked': [77], 'InTwitterEmail': [78], 'Abstract': [79], 'INTRODUCTION': [80], 'AND': [81], 'OBJECTIVES:': [82], 'Bladder': [83], 'cancer': [84, 91], '(BLCA)': [85], 'is': [86, 143, 175, 438, 478], 'the': [87, 93, 96, 108, 117, 169, 221, 236, 307, 319, 342, 392, 433, 440, 453, 465], 'sixth': [88], 'most': [89, 98, 343, 393], 'common': [90, 99], 'in': [92, 107, 160, 179, 189, 214, 248, 258, 278, 290, 298, 306, 318, 361, 383, 412, 468], 'US': [94], 'ninth': [97], 'worldwide.': [100], 'BLCA': [101, 207, 239, 253, 320, 331, 350, 400, 429, 472], 'management': [102], 'has': [103], 'not': [104, 359], 'changed': [105], 'significantly': [106], 'last': [109], '3': [110], 'decades,': [111], 'with': [112, 145, 152, 165, 203, 250, 263, 280, 353, 372, 406, 475], 'platinum-based': [113], 'chemotherapy': [114], '(MVAC)': [115], 'being': [116], 'systemic': [118], 'therapy': [119], 'choice': [121], 'since': [122], '1985.': [123], 'MVAC': [124], 'can': [125, 219, 423], 'reduce': [126], 'recurrence': [127], 'after': [128], 'tumor': [129, 397, 414], 'resection,': [130], 'but': [131], 'only': [132, 161], '50%': [133], 'patients': [135, 164], 'are': [136, 196], 'either': [137, 245], 'eligible': [138], 'or': [139, 157, 230, 247, 272, 277], 'respond,': [140], 'it': [142], 'associated': [144], 'several': [146, 215], 'life': [147], 'threatening': [148], 'toxicities.': [149], 'Breakthrough': [150], 'immunotherapy': [151], 'checkpoint': [153], 'inhibitors': [154, 205], 'produces': [155], 'partial': [156], 'complete': [158], 'responses': [159], '20-30%': [162], 'metastatic': [166], 'BLCA.': [167], 'Hence,': [168, 233], 'need': [170], 'for': [171], 'more': [172], 'therapeutic': [173, 426], 'options': [174, 427], 'paramount.': [176], 'Cells': [177], 'deficient': [178], 'homologous': [180], 'recombination': [181], '(HR)': [182], 'via': [183, 192, 439], 'loss': [184, 210], 'BRCA': [186], 'proteins': [187], 'SSB': [190], 'repair': [191], 'inactivation': [193], 'subject': [197], 'synthetic': [199], 'lethality': [200], 'when': [201], 'treated': [202, 262], '(PARPi).': [206], 'exhibit': [208], 'somatic': [209], 'function': [212], 'mutations': [213], 'HR': [216], 'genes,': [217], 'which': [218, 477], 'amplify': [220], 'effects': [222, 377, 411], 'DNA': [224], 'damage': [225], 'caused': [226], 'ionizing': [228], 'radiation': [229], 'platinum': [231], 'drugs.': [232], 'we': [234], 'tested': [235], 'sensitivity': [237], 'cells': [240, 321, 332, 351, 473], 'commercially': [242], 'available': [243], 'PARPi': [244, 267, 371, 422, 437], 'singly': [246], 'combination': [249, 279, 403], 'cisplatin.': [251, 281], 'METHODS:': [252], 'cell': [254, 347, 363, 379], 'lines': [255], 'xenografts': [257, 295], 'SCID': [259], 'mice': [260], 'were': [261, 288, 310, 341, 391], 'different': [264], 'concentrations': [265], '(niraparib,': [268], 'olaparib,': [269, 460], 'veliparib,': [270, 476], 'rucaparib,': [271, 388, 461], 'talazoparib)': [273], 'as': [274], 'single': [275], 'agents': [276], 'Cell': [282], 'survival,': [283], 'apoptosis,': [284], 'clonogenic': [286], 'ability': [287], 'measured': [289, 297], 'vitro.': [291, 384], 'Tumor': [292], 'growth': [293, 398], 'was': [296, 325, 358], 'vivo.': [299], 'The': [300, 402], 'levels': [301], 'proliferation': [303], 'apoptosis': [305, 382], 'xenograft': [308, 323], 'tumors': [309, 324], 'assessed': [311], 'using': [312, 327], 'immunohistochemistry.': [313], 'Expression': [314], 'enzymes': [317], 'examined': [326], 'Western': [328], 'blotting.': [329], 'RESULTS:': [330], 'responded': [333], 'differently': [334], 'each': [336], 'PARPi.': [337], 'Niraparib': [338], 'talazoparib': [340, 390, 463], 'effective': [344, 360, 394, 425], 'at': [345, 366, 395], 'reducing': [346, 362, 396, 413], 'survival': [348, 364, 380], 'compared': [352, 474], 'normal': [354], 'urothelial': [355], 'cells.': [356, 430], 'Veliparib': [357], 'even': [365], 'high': [367], 'concentrations.': [368], 'Combinations': [369], 'cisplatin': [373, 407], 'exhibited': [374, 408], 'strongly': [375, 409], 'additive': [376, 410], 'on': [378], 'In': [385], 'vivo,': [386], 'niraparib,': [387, 459], 'xenografts.': [401], 'olaparib': [405], 'growth.': [415], 'CONCLUSIONS:': [416], 'We': [417], 'provide': [418], 'preliminary': [419], 'evidence': [420], 'that': [421, 432, 452], 'be': [424], 'against': [428, 471], 'Given': [431], 'anti-tumor': [434], 'activity': [435, 445, 457, 470], 'inhibition': [441], 'catalytic': [444, 481], 'and/or': [446], 'trapping,': [448], 'our': [449], 'results': [450], 'suggest': [451], 'higher': [454], 'trapping': [456], 'plays': [464], 'major': [466], 'role': [467], 'their': [469], 'a': [479], 'primarily': [480], 'inhibitor.': [482], 'Source': [483], 'Funding:': [485], 'NIH/NCI': [486, 488], 'R21CA202404': [487], 'R03CA198696': [489], 'Toledo,': [490], 'OH©': [491], '2019': [492, 511], 'American': [494, 513], 'Urological': [495, 514], 'Association': [496, 515], 'Education': [497, 516], 'Research,': [499, 518], 'Inc.FiguresReferencesRelatedDetails': [500], 'Volume': [501], '201Issue': [502], 'Supplement': [503], '4April': [504], '2019Page:': [505], 'e820-e820': [506], 'Advertisement': [507, 551], 'Copyright': [508], 'Permissions©': [510], 'Inc.MetricsAuthor': [519], 'Information': [520], 'Expand': [549], 'PDF': [552], 'downloadLoading': [553], '...': [554]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2941833785', 'counts_by_year': [{'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-12T22:07:37.225096', 'created_date': '2019-05-03'}